ConductScience.org, home

Paper55648

Levamisole in prevention of recurrent upper-respiratory-tract infections in children.

Van Eygen M and 3 others. Lancet, 1976. Cited by 72 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Levamisole in prevention of recurrent upper-respiratory-tract infections in children. Papers, record 55648. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55648

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Levamisole in prevention of recurrent upper-respiratory-tract infections in children.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
2.73
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Eygen MM
2Znamensky PYP Y
3Heck EE
4Raymaekers II

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LevamisoleMajor topic
Respiratory Tract InfectionsMajor topic
Adolescent
Belgium
Child
Child, Preschool
Clinical Trials as Topic
Drug Evaluation
Female
Follow-Up Studies
Humans
Infant
Male
Placebos
Recurrence
Seasons
Time Factors

Source PubMed

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
17,054,227Immunostimulants for preventing respiratory tract infection in children.Cochrane Database Syst Rev2006https://conductscience.org/library/papers/17054227PubMed
9,769,419Regulation of murine cystic fibrosis transmembrane conductance regulator Cl- channels expressed in Chinese hamster ovary cells.J Physiol1998https://conductscience.org/library/papers/9769419PubMed
7,522,329Phosphatase inhibitors activate normal and defective CFTR chloride channels.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/7522329PubMed
6,995,093Use of levamisole in viral infections.Drugs1980https://conductscience.org/library/papers/6995093PubMed
6,995,092Use of levamisole in cancer patients.Drugs1980https://conductscience.org/library/papers/6995092PubMed
6,970,548Immunocompetence of children with frequent respiratory infections.Arch Dis Child1981https://conductscience.org/library/papers/6970548PubMed
6,716,911Immunostimulation. Clinical and experimental perspectives.Klin Wochenschr1984https://conductscience.org/library/papers/6716911PubMed
6,203,843The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.Infection1984https://conductscience.org/library/papers/6203843PubMed
2,414,227The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.Infection1985https://conductscience.org/library/papers/2414227PubMed
477,676A double-blind pediatric evaluation of levamisole in the prevention of recurrent upper respiratory tract infections.Eur J Pediatr1979https://conductscience.org/library/papers/477676PubMed
471,866Levamisole in the treatment of cyclical neutropenia.Postgrad Med J1979https://conductscience.org/library/papers/471866PubMed
341,174Immunodeficiency in children.Proc R Soc Med1977https://conductscience.org/library/papers/341174PubMed
321,165Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.Clin Exp Immunol1977https://conductscience.org/library/papers/321165PubMed
318,786Cell-mediated immunity and its role in resistance to infection.West J Med1977https://conductscience.org/library/papers/318786PubMed
312,252Inhibition of the E-rosette formation of T-lymphocytes by aggregated human IgG and restoration by levamisole.Immunology1978https://conductscience.org/library/papers/312252PubMed
306,223Defective neutrophil chemotaxis and raised serum ige levels in a child with recurrent bacterial infections and eczema. Influence of levamisole.Arch Dis Child1978https://conductscience.org/library/papers/306223PubMed
116,963Levamisole: a review and some observations in its effects on immunocompetence in protein-energy malnutrition and old age.Indian J Pediatr1979https://conductscience.org/library/papers/116963PubMed
92,398Antiviral agents: action and clinical use.Drugs1979https://conductscience.org/library/papers/92398PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55648

GET https://conductscience.org/api/papers/v1/55648/authors